Velicept Therapeutics

About:

Velicept Therapeutics is a privately held clinical development

Website: http://www.velicept.com/

Top Investors: Samsara BioCapital, Longitude Capital, CAM Capital, Fountain Healthcare Partners, CDK Associates

Description:

Velicept Therapeutics, Inc. is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs. Its lead program, solabegron, is a highly differentiated novel compound being investigated for overactive bladder (OAB) and irritable bowel syndrome (IBS). Velicept is a portfolio company of NeXeption. For more information,